4839 related articles for article (PubMed ID: 3293779)
1. Antibody directed targeting of methotrexate-containing small unilamellar vesicles.
Singh M; Faulkner G; Ghose TI; Mezei M
Cancer Immunol Immunother; 1988; 27(1):17-25. PubMed ID: 3293779
[TBL] [Abstract][Full Text] [Related]
2. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
Singh M; Ghose T; Faulkner G; Kralovec J; Mezei M
Cancer Res; 1989 Jul; 49(14):3976-84. PubMed ID: 2660984
[TBL] [Abstract][Full Text] [Related]
3. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.
Uadia P; Blair AH; Ghose T; Ferrone S
J Natl Cancer Inst; 1985 Jan; 74(1):29-35. PubMed ID: 3855485
[TBL] [Abstract][Full Text] [Related]
4. Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.
Ghose T; Ferrone S; Blair AH; Kralovec Y; Temponi M; Singh M; Mammen M
Cancer Immunol Immunother; 1991; 34(2):90-6. PubMed ID: 1760821
[TBL] [Abstract][Full Text] [Related]
5. Uptake of methotrexate linked to an anti-EL4-lymphoma antibody by EL4 cells.
Uadia P; Blair AH; Ghose T
Cancer Immunol Immunother; 1983; 16(2):127-9. PubMed ID: 6559102
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model.
Singh M; Ghose T; Mezei M; Belitsky P
Cancer Lett; 1991 Feb; 56(2):97-102. PubMed ID: 1998948
[TBL] [Abstract][Full Text] [Related]
7. The development of IL-2 conjugated liposomes for therapeutic purposes.
Konigsberg PJ; Godtel R; Kissel T; Richer LL
Biochim Biophys Acta; 1998 Mar; 1370(2):243-51. PubMed ID: 9545572
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092
[TBL] [Abstract][Full Text] [Related]
9. Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugate.
Haenseler E; Esswein A; Vitols KS; Montejano Y; Mueller BM; Reisfeld RA; Huennekens FM
Biochemistry; 1992 Jan; 31(3):891-7. PubMed ID: 1731945
[TBL] [Abstract][Full Text] [Related]
10. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
Uadia P; Blair AH; Ghose T
Cancer Res; 1984 Oct; 44(10):4263-6. PubMed ID: 6467187
[TBL] [Abstract][Full Text] [Related]
11. Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells.
Foldvari M; Mezei C; Mezei M
J Pharm Sci; 1991 Nov; 80(11):1020-8. PubMed ID: 1726112
[TBL] [Abstract][Full Text] [Related]
12. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
Shen WC; Ballou B; Ryser HJ; Hakala TR
Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human renal cancer by methotrexate linked to a monoclonal antibody.
Singh M; Kralovec J; Mezei M; Ghose T
J Urol; 1989 Feb; 141(2):428-31. PubMed ID: 2643730
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities.
Kralovec J; Spencer G; Blair AH; Mammen M; Singh M; Ghose T
J Med Chem; 1989 Nov; 32(11):2426-31. PubMed ID: 2810330
[TBL] [Abstract][Full Text] [Related]
15. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
Koizumi S; Curt GA; Fine RL; Griffin JD; Chabner BA
J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
[TBL] [Abstract][Full Text] [Related]
16. Production of a monoclonal antibody-methotrexate conjugate utilizing dextran T-40 and its biologic activity.
Manabe Y; Tsubota T; Haruta Y; Kataoka K; Okazaki M; Haisa S; Nakamura K; Kimura I
J Lab Clin Med; 1984 Sep; 104(3):445-54. PubMed ID: 6206174
[TBL] [Abstract][Full Text] [Related]
17. Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors.
Matherly LH; Angeles SM; Czajkowski CA
J Biol Chem; 1992 Nov; 267(32):23253-60. PubMed ID: 1429671
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
Affleck K; Embleton MJ
Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
[TBL] [Abstract][Full Text] [Related]
19. Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrier.
Wang X; Liu P; Yang W; Li L; Li P; Liu Z; Zhuo Z; Gao Y
Int J Nanomedicine; 2014; 9():4899-909. PubMed ID: 25364248
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical response of malignant melanoma to methotrexate in vivo and in vitro.
Gaukroger J; Wilson L; Stewart M; Farid Y; Habeshaw T; Harding N; Mackie R
Br J Cancer; 1983 May; 47(5):671-9. PubMed ID: 6601959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
